{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:17:47Z","timestamp":1790713067182,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cmi.2019.10.016","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T01:59:51Z","timestamp":1571795991000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study"],"prefix":"10.1016","volume":"26","author":[{"given":"N.","family":"Daneman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.S.","family":"Sketris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Quail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bugden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.10.016_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib3","series-title":"Canadian antimicrobial resistance surveillance system: 2017 report","year":"2018"},{"key":"10.1016\/j.cmi.2019.10.016_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.016_bib5","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.9778\/cmajo.20170100","article-title":"A\u00a0decade of outpatient antimicrobial use in older adults in Ontario: a descriptive study","volume":"5","author":"Tan","year":"2017","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cmi.2019.10.016_bib6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.016_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.324.7349.1306","article-title":"Fluoroquinolones and risk of Achilles tendon disorders: case\u2013control study","volume":"324","author":"van der Linden","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.10.016_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2019.10.016_bib9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2012.383","article-title":"Oral fluoroquinolones and the risk of retinal detachment","volume":"307","author":"Etminan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.10.016_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.0000000000000846","article-title":"Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study","volume":"83","author":"Etminan","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2019.10.016_bib11","series-title":"FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. U.S. Food and Drug Admnistration","year":"2016"},{"key":"10.1016\/j.cmi.2019.10.016_bib12","series-title":"Summary Safety Review - fluoroquinolones. Assessing the potential risk of persistent and disabling side effects","year":"2017"},{"key":"10.1016\/j.cmi.2019.10.016_bib13","series-title":"Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics","year":"2018"},{"key":"10.1016\/j.cmi.2019.10.016_bib14","first-page":"e134","article-title":"CNODES: the Canadian network for observational drug effect studies","volume":"6","author":"Suissa","year":"2012","journal-title":"Open Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1503\/cmaj.151243","article-title":"Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy","volume":"188","author":"Henry","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2019.10.016_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMoa1506115","article-title":"A\u00a0multicenter observational study of incretin-based drugs and heart failure","volume":"374","author":"Filion","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2019.10.016_bib18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2019.10.016_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.10.016_bib21","article-title":"Antimicrobial agents for treating uncomplicated urinary tract infection in women","volume":"10","author":"Zalmanovici Trestioreanu","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.10.016_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/43.suppl_1.67","article-title":"A\u00a0trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","author":"Iravani","year":"1999","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.10.016_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/jac\/dkh414","article-title":"Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim\/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study","volume":"54","author":"Arredondo-Garcia","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl.\u00a0l_4","key":"10.1016\/j.cmi.2019.10.016_bib24","doi-asserted-by":"crossref","first-page":"S393","DOI":"10.1093\/infdis\/jiw343","article-title":"A\u00a0platform for monitoring regional antimicrobial resistance, using online data sources: ResistanceOpen","volume":"214","author":"MacFadden","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.10.016_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","article-title":"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial","volume":"380","author":"Sandberg","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.10.016_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cpt1969104534","article-title":"Urinary drug excretion in man during oral dosage of different nitrofurantoin formulations","volume":"10","author":"Conklin","year":"1969","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cmi.2019.10.016_bib27","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:53Z","timestamp":1761117893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1930552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1198743X1930552X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}